<DOC>
<DOCNO>
EP-0008711
</DOCNO>
<TEXT>
<DATE>
19800319
</DATE>
<IPC-CLASSIFICATIONS>
C07D-263/20 C07D-263/24 <main>C07C-93/06</main> C07D-285/10 C07C-213/00 C07C-217/00 C07D-263/00 C07C-217/30 C07D-285/00 C07C-67/00 
</IPC-CLASSIFICATIONS>
<TITLE>
a method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether.
</TITLE>
<APPLICANT>
smithkline corpus<sep>smithkline corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline beckman corporation <sep>
</APPLICANT>
<INVENTOR>
kirkpatrick david samuel<sep>webb robert lee<sep>kirkpatrick, david samuel<sep>webb, robert lee<sep>kirkpatrick, david samuel2625 summit avenuebroomall, pennsylvania 19008us<sep>webb, robert lee512 n. veronica roadwest chester, pennsylvania 19380us<sep>kirkpatrick, david samuel <sep>webb, robert lee<sep>kirkpatrick, david samuel2625 summit avenuebroomall, pennsylvania 19008us<sep>webb, robert lee512 n. veronica roadwest chester, pennsylvania 19380us<sep>
</INVENTOR>
<ABSTRACT>
methods and intermediates for introducing the two  blocking side chains, 2-hydroxy- 3-isopropyl or tert. -­ butylaminopropyl, into aromatic nuclei containing a  phenolic hydroxyl group by condensing a 5-halomethyl-­ 3-isopropyl or 3-tert.  -butyl-2-oxazolidinone with an aroma­ tic compound containing a phenolic hydroxy group in the  presence of an acid binding agent at 80-150°c then subs­ quently splitting the oxazolidinone ring using an alkali  metal hydroxide or lower alkoxide at a temperature in the  range of 100-150°c in an organic solvent.  
</ABSTRACT>
</TEXT>
</DOC>
